Skip to main content

On This Page

← AI Financial News

MakeMyTrip – 2026-01-21 - Increase Confidence 8/10

2 min read $MMYT
Share

These articles are AI-generated summaries. Please check the original sources for full details.

MMYTMakeMyTrip Limited
$74.59-15.47 (-17.18%)
$90$80$70Oct 21Dec 4Jan 20
52W High: $90.0652W Low: $69.85Volume: 1.65M
NasdaqGS
Prediction (2/4/2026):High: $120.73Low: $65.53Ref Price: $65.54
This chart shows historical data as of January 20, 2026. Not updated in real-time.

MMYT – Increase in Days/Weeks

MakeMyTrip reported 15.4% YoY revenue growth in Q3 FY26 to $295.7 million, driven by a 20.3% surge in hotel-room nights, even as net income dipped due to forex and financing costs. The stock reacted positively, closing up 0.93% at $74.59 the day after the earnings release, indicating strong market confidence.

Why This Matters

Despite a high debt/equity ratio and volatile net income, MakeMyTrip’s core business is gaining traction in high-margin segments like hotels and packages, which are less sensitive to fuel and capacity constraints than air ticketing. With the Q3 earnings beat released on January 21, 2026—the same day as this analysis—the market is likely to re-rate the stock upward in the short term, especially given the strong free cash flow of $173.5 million and a forward P/E that has corrected to 28.6, suggesting improved earnings expectations.

Key Insights

  • Revenue +15.4% YoY, Q3 FY26: Revenue reached $295.7 million, reflecting sustained demand in leisure travel and effective cross-brand monetization across MakeMyTrip, Goibibo, and redBus.
  • News Impact: Q3 earnings beat with strong hotel and package growth triggered immediate positive price action, closing at $74.59—above current levels—indicating momentum.
  • Risk/Offset: High debt/equity (4,659%) and past net losses raise structural concerns, but improving adjusted profits and cash flow suggest deleveraging may be underway.

Practical Implications

  • Bull Case: Continued investor focus on quality of earnings and segment growth could push the stock toward $80–$85 in the next 2–3 weeks, especially if broader market sentiment remains stable.
  • Bear Case: If macro concerns over Indian consumer spending or currency volatility resurface, the high P/E (96.4) could amplify downside risk back toward $65.
  • Confidence: 8/10 – Strong earnings momentum, solid cash flow, and positive price reaction support near-term upside.

Prediction: increase

Reference:

Continue reading

Next article

Moderna – 2026-01-21 - Increase Confidence 8/10

Related Content